title: Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors.
authors.affiliation: Pittsburgh Transplantation Institute and Department of Pathology, University of Pittsburgh, Pennsylvania 15213, USA.
authors.forename: P
authors.initials: P
authors.lastname: Grossi
authors.forename: S
authors.initials: S
authors.lastname: Kusne
authors.forename: C
authors.initials: C
authors.lastname: Rinaldo
authors.forename: K
authors.initials: K
authors.lastname: St George
authors.forename: M
authors.initials: M
authors.lastname: Magnone
authors.forename: J
authors.initials: J
authors.lastname: Rakela
authors.forename: J
authors.initials: J
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation; D010750:Phosphoproteins / Q000097:blood*; D014019:Tissue Donors; D014763:Viral Matrix Proteins / Q000097:blood*
chemical_list: D000998:Antiviral Agents; D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa; D015774:Ganciclovir